ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE-ACTIVATED KILLER CELLS PLUS RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA

被引：41
|
作者：
ONISHI, S
SAIBARA, T
FUJIKAWA, M
SAKAEDA, H
MATSUURA, Y
MATSUNAGA, Y
YAMAMOTO, Y
机构：
来源：
HEPATOLOGY | 1989年 / 10卷 / 03期
关键词：
D O I：
10.1002/hep.1840100318
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：349 / 353
页数：5
相关论文
共 50 条
  • [31] ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE ACTIVATED KILLER (LAK) CELLS AND RECOMBINANT INTERLEUKIN-2 (RIL-2) FOR RECURRENT GLIOBLASTOMA
    MERCHANT, RE
    MERCHANT, LH
    YOUNG, HF
    JOURNAL OF NEURO-ONCOLOGY, 1987, 5 (02) : 177 - 177
  • [32] CONTINUOUS INFUSION OF RECOMBINANT INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS IN REFRACTORY MALIGNANCIES
    CHRISTIANSEN, NP
    KENNEDY, BJ
    OCHOA, AC
    SKUBITZ, KM
    BACH, FH
    MEDICAL AND PEDIATRIC ONCOLOGY, 1989, 17 (06): : 455 - 458
  • [33] PREPARATIVE CYTOREDUCTIVE SURGERY IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA TREATED WITH ADOPTIVE IMMUNOTHERAPY WITH INTERLEUKIN-2 OR INTERLEUKIN-2 PLUS LYMPHOKINE ACTIVATED KILLER-CELLS
    ROBERTSON, CN
    LINEHAN, WM
    PASS, HI
    GOMELLA, LG
    HAAS, GP
    BERMAN, A
    MERINO, M
    ROSENBERG, SA
    JOURNAL OF UROLOGY, 1990, 144 (03): : 614 - 618
  • [34] IMMUNOTHERAPY WITH LYMPHOKINE-ACTIVATED NATURAL-KILLER-CELLS AND RECOMBINANT INTERLEUKIN-2 - A FEASIBILITY TRIAL IN METASTATIC RENAL-CELL CARCINOMA
    HERCEND, T
    FARACE, F
    BAUME, D
    CHARPENTIER, F
    DROZ, JP
    TRIEBEL, F
    ESCUDIER, B
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1990, 9 (06): : 546 - 555
  • [35] CIRCULATING CYTOKINES IN PATIENTS WITH METASTATIC CANCER TREATED WITH RECOMBINANT INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS
    GEMLO, BT
    PALLADINO, MA
    JAFFE, HS
    ESPEVIK, TP
    RAYNER, AA
    CANCER RESEARCH, 1988, 48 (20) : 5864 - 5867
  • [36] SYNERGY OF HUMAN RECOMBINANT INTERLEUKIN-1 WITH INTERLEUKIN-2 IN THE GENERATION OF LYMPHOKINE-ACTIVATED KILLER CELLS
    CRUMP, WL
    OWENSCHAUB, LB
    GRIMM, EA
    CANCER RESEARCH, 1989, 49 (01) : 149 - 153
  • [37] IMMUNOTHERAPY OF TUMORS WITH INTERLEUKIN-2 AND LYMPHOKINE ACTIVATED KILLER CELLS
    JOST, LM
    GMUR, J
    OELZ, O
    SAUTER, C
    STAHEL, RA
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1989, 119 (05) : 137 - 143
  • [38] CANCER-IMMUNOTHERAPY - CURRENT STATUS OF TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS
    VANHAELSTPISANI, CM
    PISANI, RJ
    KOVACH, JS
    MAYO CLINIC PROCEEDINGS, 1989, 64 (04) : 451 - 465
  • [39] GENERATION OF LYMPHOKINE-ACTIVATED KILLER (LAK) ACTIVITY INVIVO WITH RECOMBINANT INTERLEUKIN-2
    THOMPSON, JA
    CHEEVER, MA
    KERN, DE
    GREENBERG, PD
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 318 - 318
  • [40] THE ANTI-TUMOR EFFICACY OF LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 INVIVO
    MULE, JJ
    SHU, S
    ROSENBERG, SA
    JOURNAL OF IMMUNOLOGY, 1985, 135 (01): : 646 - 652
12345